Episode 10 - Drivers of Cost in Cardiometabolic Management

During this segment, the panelists discuss the highest drivers of cost when managing cardiometabolic disease. Michael Weber, MD, explains that adverse events cause costs to rise dramatically and Kenneth L. Schaecher, MD, FACP, CPC, clarifies the fact that from a managed care standpoint, the greatest proportion of dollars are spent on inpatient services.

David Calabrese, RPh, MHP, claims that 70% of the dollars spent today are used to manage factors associated with diabetes, including cardiovascular comorbidities, and explains that the dollars are used to try to prevent other negative sequalae from occurring down the road.

Additionally, the panelists explain that the topic of the costs associated with cardiometabolic management is controversial. Dr Schaecher explains that preventing cardiometabolic events can be more expensive than treating an event on a firsthand basis due to the costs of drugs for the treatment of long-term conditions, or risk factors.